267
Views
5
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Changes in the diagnosis and treatment of patients with low grade lymphoma in Germany: years 2006–2009

, , , , , , , , , , , & show all
Pages 694-702 | Received 02 Dec 2013, Accepted 21 May 2014, Published online: 19 Aug 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Luca Fischer & Martin Dreyling. (2023) Follicular lymphoma: an update on biology and optimal therapy. Leukemia & Lymphoma 64:4, pages 761-775.
Read now
Dirk Müller, Kirsten Fischer, Peter Kaiser, Barbara Eichhorst, Ronald Walshe, Marcel Reiser, Lenka Kellermann, Lisa Borsi, Daniele Civello, Alexander Mensch, Jasmin Bahlo, Michael Hallek, Stephanie Stock & Günter Fingerle-Rowson. (2016) Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia. Leukemia & Lymphoma 57:5, pages 1130-1139.
Read now

Articles from other publishers (3)

Anna Zoellner, Klaus Herfarth, Michael Herold, Wolfram Klapper, Nicole Skoetz & Wolfgang Hiddemann. (2021) Follicular Lymphoma—Diagnosis, Treatment, and Follow-Up. Deutsches Ärzteblatt international.
Crossref
Louisa Adolph & Oliver Weigert. (2021) Von prognostischen Risikomodellen zu prädiktiven Biomarkern. Im Fokus Onkologie 24:2, pages 16-21.
Crossref
Anna-Katharina Zoellner, Thomas Höhler, Stefan Fries, Angelika Böhme, Philipp Kiewe, Lenka Kellermann & Martin Dreyling. (2016) Altered treatment of chronic lymphocytic leukemia in Germany during the last decade. Annals of Hematology 95:6, pages 853-861.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.